Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma, Clin Cancer Res, vol.22, issue.2, pp.291-300, 2016. ,
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma, J Hepatol, vol.60, issue.6, pp.1268-89, 2014. ,
Changing pattern of epidemiology in intrahepatic cholangiocarcinoma ,
, Hepatology, vol.60, issue.3, pp.1107-1115, 2014.
Pathogenesis, diagnosis, and management of cholangiocarcinoma ,
, Gastroenterology, vol.145, issue.6, pp.1215-1244, 2013.
Emerging molecular therapeutic targets for cholangiocarcinoma, J Hepatol, 2017. ,
Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution, Ann Surg, vol.245, issue.5, pp.755-62, 2007. ,
,
, Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer, N Engl J Med, vol.362, issue.14, pp.1273-81, 2010.
Long-range regulation at the SOX9 locus in development and disease, J Med Genet, vol.46, issue.10, pp.649-56, 2009. ,
Understanding the role of SOX9 in acquired diseases: lessons from development, Trends Mol Med, vol.17, issue.3, pp.166-74, 2011. ,
The versatile functions of Sox9 in development, stem cells, and human diseases, Genes Dis, vol.1, issue.2, pp.149-61, 2014. ,
Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9, Gastroenterology, vol.136, issue.7, pp.2325-2358, 2009. ,
Organogenesis and development of the liver, Dev Cell, vol.18, issue.2, pp.175-89, 2010. ,
Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages, J Anat, vol.220, issue.2, pp.186-99, 2012. ,
Sox9 and programming of liver and pancreatic progenitors, J Clin Invest, vol.123, issue.5, pp.1881-1887, 2013. ,
Lineage fate of ductular reactions in liver injury and carcinogenesis, J Clin Invest, vol.125, issue.6, pp.2445-57, 2015. ,
Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets, Hepatology, vol.54, issue.6, pp.2159-72, 2011. ,
Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/beta-catenin signaling, Oncotarget, vol.7, issue.20, pp.29371-86, 2016. ,
Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma, Hepatology, vol.64, issue.1, pp.117-146, 2016. ,
Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma, Dig Liver Dis, vol.47, issue.12, pp.1067-75, 2015. ,
The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis, Hepatology, vol.50, issue.1, pp.230-273, 2009. ,
Caveolin-1 abrogates TGF-beta mediated hepatocyte apoptosis, Cell Death Dis, vol.4, p.466, 2013. ,
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data, Nucleic Acids Res, vol.33, issue.20, p.175, 2005. ,
Cell cycle proteins as promising targets in cancer therapy, Nat Rev Cancer, vol.17, issue.2, pp.93-115, 2017. ,
EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features, Gastroenterology, vol.136, issue.3, pp.1012-1036, 2009. ,
Eyes wide open: a critical review of sphereformation as an assay for stem cells, Cell Stem Cell, vol.8, issue.5, pp.486-98, 2011. ,
MALAT1-miR-101SOX9 feedback loop modulates the chemo-resistance of lung cancer cell to DDP via Wnt signaling pathway, Oncotarget, vol.8, issue.55, pp.94317-94346, 2017. ,
SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell, Cell Cycle, vol.2017, pp.1-34 ,
,
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance, Expert Opin Ther Targets, vol.20, issue.4, pp.393-405, 2016. ,
Downregulation of microRNA-206 promotes invasion and angiogenesis of triple negative breast cancer, Biochem Biophys Res Commun, vol.477, issue.3, pp.461-467, 2016. ,
Stability and prognostic value of Slug, Sox9 and Sox10 expression in breast cancers treated with neoadjuvant chemotherapy, Springerplus, vol.2, p.695, 2013. ,
Upregulation of microRNA524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9, Oncotarget, vol.8, issue.1, pp.574-82, 2017. ,
Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer, Eur J Pharmacol, vol.741, pp.8-16, 2014. ,
Cellular processing of platinum anticancer drugs, Nat Rev Drug Discov, vol.4, issue.4, pp.307-327, 2005. ,